Follow-up Study to Evaluate the Long-term Efficacy of a HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
Latest Information Update: 24 Oct 2023
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 05 Feb 2013 New trial record
- 16 Jul 2010 7.3 year follow-up results published in Vaccine.